Selective small-molecule modulators of disease-relevant human cytochrome P450 enzymes

Pallomino Therapeutics is an early-stage drug discovery company developing cell-based platforms to identify novel modulators of human cytochrome P450 enzymes.Our initial focus is on CNS-relevant targets that impact neurological disease.

Pallomino Therapeutics · Toronto, Canada Non-confidential overview · © 2026